16.74USD-2.90%Mkt Cap: 1.30B $P/E: —2d ago
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operate…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap1.30B $
Enterprise Value3.07B $
Revenue (TTM)1.65B $
Gross Profit831.62M $
Net Income (TTM)-516.47M $
Revenue/Share21.41 USD
Last Price16.74 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees4.4K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS4579852082
Valuation
P/E (Trailing)—
P/E (Forward)6.37
PEG0.67
EV/EBITDA9.68
EV/Revenue1.86
P/S0.78
P/B1.24
EPS (TTM)-0.09
EPS (Forward)2.61
52W Range
8.70068% of range20.49
52W High20.49 USD
52W Low8.700 USD
Profitability
Gross Margin50.86%
Oper. Margin9.62%
EBITDA Margin19.23%
Profit Margin-31.58%
ROE-49.50%
ROA-14.34%
Growth
Revenue Growth0.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF50.38M $
CapEx (TTM)95.64M $
FCF Margin5.73%
FCF Yield7.25%
Net Debt1.78B $
Net Debt/EBITDA5.60
Balance Sheet
Debt/Equity1.95
Current Ratio3.60
Quick Ratio1.64
Book Value/Sh13.41 USD
Cash/Share3.524 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split2:1
Split DateJan 4, 2017
Analyst Consensus
Rating—
Target (Mean)19.56 USD
Upside (mean)+16.8%
Target Range14.00 USD – 27.00 USD
$14.00+16.8% to mean$27.00
# Analysts9
Ownership
Shares Out.77.77M
Float58.68M
Insiders14.30%
Institutions98.23%
Short Interest
Short Ratio6.5d
Short % Float11.48%
Short % Out.8.33%
Shares Short6.48M
Short (prev mo.)6.39M
Technical
SMA 5017.99 (-7.0%)
SMA 20013.51 (+23.9%)
Beta1.21
S&P 52W Chg18.16%
Avg Vol (30d)860.44K
Avg Vol (10d)596.67K
Technical Indicators
RSI (14)42.2
MACD-0.1809
MACD Signal-0.0962
MACD Hist.-0.0847
BB Upper19.76 USD
BB Middle17.79 USD
BB Lower15.81 USD
BB Width22.21%
ATR (14)0.9209 USD
Vol Ratio (20d)0.62x